0000899243-20-017109.txt : 20200618 0000899243-20-017109.hdr.sgml : 20200618 20200618173216 ACCESSION NUMBER: 0000899243-20-017109 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200616 FILED AS OF DATE: 20200618 DATE AS OF CHANGE: 20200618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stehman-Breen Catherine CENTRAL INDEX KEY: 0001702233 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39319 FILM NUMBER: 20973677 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Generation Bio Co. CENTRAL INDEX KEY: 0001733294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 814301281 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 857-529-5908 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-16 0 0001733294 Generation Bio Co. GBIO 0001702233 Stehman-Breen Catherine C/O GENERATION BIO CO., 301 BINNEY STREET CAMBRIDGE MA 02142 1 0 0 0 Common Stock 2020-06-16 4 C 0 5062 A 47523 D Series C Preferred Stock 2020-06-16 4 C 0 8942 0.00 D Common Stock 5062 0 D On June 16, 2020, the Series C Preferred Stock automatically converted into Common Stock on a 1.7663-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date. /s/ Jennifer Elliott, Attorney-in-Fact 2020-06-18